Study of Avelumab With or Without Entinostat in Participants With Advanced Epithelial Ovarian Cancer
Clinical trial NCT02915523 · COMPLETED
Trial details
- NCT number
- NCT02915523
- Sponsor
- Syndax Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-19
- Primary completion
- 2019-02-21
- Enrollment
- 140
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.